
Galapagos NV GLPG
$ 28.79
1.41%
Annual report 2025
added 04-18-2026
Galapagos NV EV/EBITDA Ratio 2011-2026 | GLPG
Annual EV/EBITDA Ratio Galapagos NV
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -26.5 | -26.8 | -4.83 | -165 | -42 | 1.04 K | -16.3 | -13.7 | -68.5 | -746 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 K | -746 | -6.77 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
-2.15 | $ 3.13 | 0.55 % | $ 651 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Exelixis
EXEL
|
18.1 | $ 46.48 | 4.64 % | $ 12.6 B | ||
|
Fortress Biotech
FBIO
|
-0.152 | $ 2.5 | 1.63 % | $ 69.8 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-3.66 | - | - | $ 269 M | ||
|
Genmab A/S
GMAB
|
2.7 | $ 27.79 | 0.92 % | $ 17.1 B | ||
|
Genprex
GNPX
|
-4.81 | $ 0.9 | 1.12 % | $ 839 K | ||
|
Grifols, S.A.
GRFS
|
13.7 | $ 8.33 | 0.73 % | $ 6.83 B | ||
|
InflaRx N.V.
IFRX
|
-3.65 | $ 2.51 | 27.51 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
-106 | $ 0.8 | 1.39 % | $ 6.7 M | ||
|
Ionis Pharmaceuticals
IONS
|
-363 | $ 76.27 | 1.36 % | $ 12.2 B | ||
|
BioNTech SE
BNTX
|
4.1 | $ 95.08 | -0.44 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Kamada Ltd.
KMDA
|
-386 | $ 8.28 | 0.85 % | $ 260 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | ||
|
Kymera Therapeutics
KYMR
|
-21.5 | $ 85.67 | 3.58 % | $ 7.24 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-1.24 | $ 13.28 | -1.26 % | $ 1.76 B | ||
|
INmune Bio
INMB
|
-3.64 | $ 1.54 | - | $ 38.1 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
19.4 | $ 232.25 | -0.02 % | $ 4.25 B | ||
|
Liquidia Corporation
LQDA
|
-6.02 | $ 41.83 | 4.24 % | $ 3.6 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 22.89 | 2.42 % | $ 3.79 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-3.46 | $ 108.2 | 2.26 % | $ 5.43 B | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
MannKind Corporation
MNKD
|
-32.8 | $ 3.84 | 34.27 % | $ 1.17 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 3.51 | 0.29 % | $ 5.78 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 23.68 | 1.09 % | $ 3.01 B | ||
|
Nanobiotix S.A.
NBTX
|
-4.62 K | $ 41.17 | 18.39 % | $ 286 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M |